Shorepoint Capital Partners LLC Biogen Inc. Transaction History

Shorepoint Capital Partners LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$282.99 - $369.05 $632,765 - $825,195	-2,236 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$242.95 - $284.63 $12,633 - $14,800	52 Added 2.38%	2,236 $626,000
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $10,159 - $15,292	43 Added 2.01%	2,184 $535,000
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $16,945 - $19,565	64 Added 3.08%	2,141 $607,000
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $187,269 - $248,006	-724 Reduced 25.85%	2,077 $556,000
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $25,271 - $32,057	-94 Reduced 3.25%	2,801 $886,000
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $26,847 - $37,096	-122 Reduced 4.04%	2,895 $859,000
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $20,004 - $22,436	92 Added 3.15%	3,017 $702,000
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $226,526 - $249,696	1,033 Added 54.6%	2,925 $684,000
Q1 2019 Apr 12, 2019	BUY	$216.71 - $338.96 $410,015 - $641,312	1,892 New	1,892 $447,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Shorepoint Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Shorepoint Capital Partners LLC with notifications on news.